Asia-Pacific Bioinformatics Market Size, Share, Forecast and Outlook (2024-2031)

Asia-Pacific Bioinformatics Market is segmented By Type (Knowledge Management Tools, and Bioinformatics Software and Services) By Application (Genomics & Drug Development, Proteomics, Transcriptomics and Others) and By Country (China, Japan, India, and Rest of Asia Pacific) – Share, Size, Outlook, and Opportunity Analysis, 2023-2030

Report Overview

The Asia Pacific Bioinformatics Market is expected to grow at a CAGR of 21.4% during the forecast period 2023-2030.

Bioinformatics is a branch of science that integrates computer programming, big data, and Molecular Biology to help scientists comprehend and detect patterns in biological data. It is especially valuable in genome research and DNA sequencing since it helps scientists to arrange vast volumes of data.

There are several fields of Biology to specialize in, ranging from genetics to toxicology to mycology and radiobiology. Bioinformatics is one of the fascinating topics that allows you to find, assess, store, and retrieve biological information. As an interdisciplinary topic of research, it combines applications of Computer Science, Statistics, and Biology to create software applications for interpreting biological data such as DNA sequencing, protein analysis, evolutionary genetics, and so on.

Important bioinformatics choices on drug development will be made in the future by individuals who not only understand biology but can also utilize bioinformatics tools and the information they release to create hypotheses and find excellent targets.

Asia-Pacific Bioinformatics Market Scope

For more details on this report Request for Sample

Market Drivers

Increasing Public-Private Sector Funding for Bioinformatics

In order to enhance the workflow for bioinformatics, federal authorities, as well as public and commercial organizations, are giving funding to carry out bioinformatics projects and to scientists for research. It is critical to approach potential funders with a clear plan and strategy for achieving bioinformatics capacity development at the institution, as well as the desired outputs and objectives.

For example, in April 2022, Illumina, Inc. launched a six-month cycle fundraising round for bioinformatics startups in the San Francisco Bay Area or Cambridge, U.K.

SOPHiA GENETICS secured USD 110 million in investment for the next stage of its growth in October 2020, with a focus on meeting the expanding clinical and biopharma need for Data-Driven Medicine globally.

The support from both the public and commercial sectors would result in an increase in the number of bioinformatics businesses and initiatives. The funds would be used to accelerate and extend the institute's technological infrastructure. This involves both the installation of new data storage systems and the expansion of current data resources. The funds will also be utilized to create safe, shared analytical tools for large research partnerships. As a result, public-private collaboration in bioinformatics financing is likely to boost market growth.

Market Restraints

High prices, a shortage of skilled workers, a lack of user-friendly technologies, and a lack of compatibility across diverse data formats are the restraints of the market.

Market Growth Opportunities

Strategic Initiatives by Market Players Creates Significant Opportunities for the Market

Bioinformatics, a branch of life science concerned with genome understanding and planning, provides useful biological information. A genome is the complex organization of genetic sets found in a cell or a living entity as a whole. Personalized medicine is a multifaceted approach to dealing with individual health care needs. Bioinformatics techniques aided in the creation of patient-specific medications.

For example, Quest Diagnostics Incorporated invested in Structural Bioinformatics, A Leader in Computational Proteomics, and Structural Pharmacogenomics in December 2020. The investment resulted in the combined production of a series of database modules of innovative, structurally variant proteins, as well as the direct marketing of these goods to the pharmaceutical and biotechnology industries for use in the development of customized medicine.

As a result of the rising frequency of chronic illness and increased drug-resistance difficulties in conventional therapy, there is a greater need for improved bioinformatics in drug development. This is anticipated to be one of the primary factors driving market expansion over the projected period.

Asia-Pacific Bioinformatics Market Segmentation 

The Asia Pacific bioinformatics market is segmented by type, and application.

Based on application, the genomics segment is expected to dominate the market over the forecast years. It is largely attributed to different technical improvements connected with handling a large number of genomic data, as well as the growing demand for pharmacogenomics in sequence screening and medication development.

Furthermore, expanding prospects and potential relevance of genomes in clinical research are driving demand for genomics applications and enhancing the growth of the Asia-Pacific bioinformatics market.

Industry Development

• In March 2022, Thermo Fisher Scientific Inc introduced the CE-IVD Marked Next-Generation Sequencing (NGS) Instrument for Use in Clinical Labs. The CE-IVD Marked Next-Generation Sequencing Instrument combines diagnostic testing and clinical research on a single platform. The instrument's debut resulted in the addition of a new product to the product line as well as the distribution of the NGS instrument, which is projected to improve product revenue.

Geographical Insights

By country the Asia Pacific bioinformatics market is segmented into China, Japan, India, and Rest of Asia Pacific.

China is expected to dominate the market due to an increase in R&D activity, as well as integrated bioinformatics requirements in proteomic, genomic, and clinical diagnostics, combined with a surge in demand for advanced computational tools in biological research.

Asia-Pacific Bioinformatics Key Market Players

The key players included in the Asia Pacific bioinformatics market are Thermo Fisher Scientific Inc., Illumina, Inc., Agilent Technologies, Inc., QIAGEN, SOPHiA GENETICS., BGI, Eurofins Scientific, Water Corporation, Partek Incorporated, DNASTAR, Dassault Systèmes, Bayer AG, DNANEXUS, INC., PerkinElmer Inc., Seven Bridges Genomics, Quest Diagnostics Incorporated., AstridBio Technologies Inc., BioBam, and GenoFAB, Inc.